Cytolethal distending toxin B inoculation leads to distinct gut microtypes and IBS-D-like microRNA-mediated gene expression changes in a rodent model

References

• Ford AC, Lacy BE, Talley NJ, Longo DL. Irritable bowel syndrome. N Engl J Med. 2017;376(26):2566–25. doi:10.1056/NEJMra1607547.
   PubMed Web of Science ®Google Scholar
• Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. Lancet. 2020;396:1675–1688. doi:10.1016/S0140-6736(20)31548-8.
   PubMed Web of Science ®Google Scholar
• Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, Whitehead WE, Dumitrascu DL, Fang X, Fukudo S, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology. 2021;160:99–114 e3. doi:10.1053/j.gastro.2020.04.014.
   PubMed Web of Science ®Google Scholar
• Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel disorders. Gastroenterology. 2016;150:1393–1407.e5. doi:10.1053/j.gastro.2016.02.031.
   Web of Science ®Google Scholar
• Pimentel M, Saad RJ, Long MD, Rao SSC. ACG clinical guideline: small intestinal bacterial overgrowth. Am J Gastroenterol. 2020;115:165–178. doi:10.14309/ajg.0000000000000501.
   PubMed Web of Science ®Google Scholar
• Shah ED, Riddle MS, Chang C, Pimentel M. Estimating the contribution of acute gastroenteritis to the overall prevalence of irritable bowel syndrome. J Neurogastroenterol Motil. 2012;18:200–4. doi:10.5056/jnm.2012.18.2.200.
   PubMed Web of Science ®Google Scholar
• Villanueva-Millan MJ, Leite G, Wang J, Morales W, Parodi G, Pimentel ML, Barlow GM, Mathur R, Rezaie A, Sanchez M, et al. Methanogens and hydrogen sulfide producing bacteria guide distinct gut microbe profiles and irritable bowel syndrome subtypes. Am J Gastroenterol. 2022;117(12):2055–2066. doi:10.14309/ajg.0000000000001997.
   PubMed Web of Science ®Google Scholar
• Klem F, Wadhwa A, Prokop LJ, Sundt WJ, Farrugia G, Camilleri M, Singh S, Grover M. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis. Gastroenterology. 2017;152:1042–1054.e1. doi:10.1053/j.gastro.2016.12.039.
   PubMed Web of Science ®Google Scholar
• Takakura W, Kudaravalli P, Chatterjee C, Pimentel M, Riddle MS. Campylobacter infection and the link with irritable bowel syndrome: on the pathway towards a causal association. Pathog Dis. 2022;80:80. doi:10.1093/femspd/ftac003.
   Web of Science ®Google Scholar
• Pimentel M, Chatterjee S, Chang C, Low K, Song Y, Liu C, Morales W, Ali L, Lezcano S, Conklin J, et al. A new rat model links two contemporary theories in irritable bowel syndrome. Dig Dis Sci. 2008;53(4):982–989. doi:10.1007/s10620-007-9977-z.
   PubMed Web of Science ®Google Scholar
• Pokkunuri V, Pimentel M, Morales W, Jee S-R, Alpern J, Weitsman S, Marsh Z, Low K, Hwang L, Khoshini R, et al. Role of cytolethal distending toxin in altered stool form and bowel phenotypes in a rat model of post-infectious irritable bowel syndrome. J Neurogastroenterol Motil. 2012;18(4):434–442. doi:10.5056/jnm.2012.18.4.434.
   PubMed Web of Science ®Google Scholar
• Pimentel M, Morales W, Pokkunuri V, Brikos C, Kim SM, Kim SE, Triantafyllou K, Weitsman S, Marsh Z, Marsh E, et al. Autoimmunity links vinculin to the pathophysiology of chronic functional bowel changes following Campylobacter jejuni infection in a rat model. Dig Dis Sci. 2015;60(5):1195–1205. doi:10.1007/s10620-014-3435-5.
   PubMed Web of Science ®Google Scholar
• Pickett CL, Whitehouse CA. The cytolethal distending toxin family. Trends Microbiol. 1999;7(7):292–297. doi:10.1016/S0966-842X(99)01537-1.
   PubMed Web of Science ®Google Scholar
• Morales W, Triantafyllou K, Parodi G, Weitsman S, Park SC, Rezaie A, Pichetshote N, Lin E, Pimentel M. Immunization with cytolethal distending toxin B produces autoantibodies to vinculin and small bowel bacterial changes in a rat model of postinfectious irritable bowel syndrome. Neurogastroenterol Motil. 2020;32:e13875. doi:10.1111/nmo.13875.
   PubMed Web of Science ®Google Scholar
• Farzaei MH, Bahramsoltani R, Abdollahi M, Rahimi R. The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatments. J Neurogastroenterol Motil. 2016;22:558–574. doi:10.5056/jnm16001.
   PubMed Web of Science ®Google Scholar
• Sikander A, Rana SV, Prasad KK. Role of serotonin in gastrointestinal motility and irritable bowel syndrome. Clin Chim Acta. 2009;403(1–2):47–55. doi:10.1016/j.cca.2009.01.028.
   PubMed Web of Science ®Google Scholar
• Hyland NP, Quigley EM, Brint E. Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions. World J Gastroenterol. 2014;20(27):8859–8866. doi:10.3748/wjg.v20.i27.8859.
   PubMed Web of Science ®Google Scholar
• Bravo-Vazquez LA, Medina-Rios I, Marquez-Gallardo LD, Reyes-Muñoz J, Serrano-Cano FI, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S, et al. Functional implications and clinical potential of MicroRNAs in irritable bowel syndrome: a concise review. Dig Dis Sci. 2023;68(1):38–53. doi:10.1007/s10620-022-07516-6.
   PubMed Web of Science ®Google Scholar
• Leite G, Morales W, Weitsman S, Celly S, Parodi G, Mathur R, Barlow GM, Sedighi R, Millan MJV, Rezaie A, et al. The duodenal microbiome is altered in small intestinal bacterial overgrowth. Plos One. 2020;15(7):e0234906. doi:10.1371/journal.pone.0234906.
   PubMed Web of Science ®Google Scholar
• Fernandez-Calleja JMS, Konstanti P, Swarts HJM, Bouwman LMS, Garcia-Campayo V, Billecke N, Oosting A, Smidt H, Keijer J, van Schothorst EM, et al. Non-invasive continuous real-time in vivo analysis of microbial hydrogen production shows adaptation to fermentable carbohydrates in mice. Sci Rep. 2018;8(1):15351. doi:10.1038/s41598-018-33619-0.
   PubMedGoogle Scholar
• Klapholz B, Brown NH. Talin - the master of integrin adhesions. J Cell Sci. 2017;130:2435–2446. doi:10.1242/jcs.190991.
   PubMed Web of Science ®Google Scholar
• Parsanathan R, Jain SK. Hydrogen sulfide regulates circadian-clock genes in C2C12 myotubes and the muscle of high-fat-diet-fed mice. Arch Biochem Biophys. 2019;672:108054. doi:10.1016/j.abb.2019.07.019.
   PubMed Web of Science ®Google Scholar
• Kim DS, Anantharam P, Padhi P, Thedens DR, Li G. Transcriptomic profile analysis of brain inferior colliculus following acute hydrogen sulfide exposure. Toxicology. 2020;430:152345. doi:10.1016/j.tox.2019.152345.
   PubMed Web of Science ®Google Scholar
• Bravo-Vázquez LA, Medina-Ríos I, Márquez-Gallardo LD, Reyes-Muñoz J, Serrano-Cano FI, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S, et al. Functional implications and clinical potential of MicroRNAs in irritable bowel syndrome: a concise review. Dig Dis Sci. 2022;68:38–53. doi:10.1007/s10620-022-07516-6.
   PubMed Web of Science ®Google Scholar
• Singh R, Zogg H, Ro S. Role of microRnas in disorders of gut–brain interactions: clinical insights and therapeutic alternatives. J Pers Med. 2021;11:11. doi:10.3390/jpm11101021.
   Web of Science ®Google Scholar
• Park C, Lee MY, Slivano OJ, Park PJ, Ha S, Berent RM, Fuchs R, Collins NC, Yu TJ, Syn H, Park J. Loss of serum response factor induces microRNA-mediated apoptosis in intestinal smooth muscle cells. Cell Death Dis 2015;6:e2011.
   PubMed Web of Science ®Google Scholar
• Hou Q, Huang Y, Zhang C, Zhu S, Li P, Chen X, Hou Z, Liu F. MicroRNA-200a targets cannabinoid receptor 1 and serotonin transporter to increase visceral hyperalgesia in diarrhea-predominant irritable bowel syndrome rats. J Neurogastroenterol Motil. 2018;24:656–668. doi:10.5056/jnm18037.
   PubMed Web of Science ®Google Scholar
• Chao G, Wang Y, Zhang S, Yang W, Ni Z, Zheng X. MicroRNA-29a increased the intestinal membrane permeability of colonic epithelial cells in irritable bowel syndrome rats. Oncotarget. 2017;8:85828–85837. doi:10.18632/oncotarget.20687.
   PubMedGoogle Scholar
• Nakata K, Sugi Y, Narabayashi H, Kobayakawa T, Nakanishi Y, Tsuda M, Hosono A, Kaminogawa S, Hanazawa S, Takahashi K, et al. Commensal microbiota-induced microRNA modulates intestinal epithelial permeability through the small GTPase ARF4. J Biol Chem. 2017;292(37):15426–15433. doi:10.1074/jbc.M117.788596.
   PubMed Web of Science ®Google Scholar
• Mahurkar-Joshi S, Rankin CR, Videlock EJ, Soroosh A, Verma A, Khandadash A, Iliopoulos D, Pothoulakis C, Mayer EA, Chang L, et al. The colonic mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p are downregulated in irritable bowel syndrome and are associated with barrier function and MAPK signaling. Gastroenterology. 2021;160(7):2409–2422.e19. doi:10.1053/j.gastro.2021.02.040.
   PubMed Web of Science ®Google Scholar
• Fourie NH, Peace RM, Abey SK, Sherwin LB, Rahim-Williams B, Smyser PA, Wiley JW, Henderson WA. Elevated circulating miR-150 and miR-342-3p in patients with irritable bowel syndrome. Exp Mol Pathol. 2014;96:422–5. doi:10.1016/j.yexmp.2014.04.009.
   PubMed Web of Science ®Google Scholar
• Ye D, Guo S, Al-Sadi R, Ma TY. MicroRNA regulation of intestinal epithelial tight junction permeability. Gastroenterology. 2011;141:1323–33. doi:10.1053/j.gastro.2011.07.005.
   PubMed Web of Science ®Google Scholar
• Zhu H, Xiao X, Shi Y, Wu Y, Huang Y, Li D, Xiong F, He G, Chai Y, Tang H, et al. Inhibition of miRNA‑29a regulates intestinal barrier function in diarrhea‑predominant irritable bowel syndrome by upregulating ZO‑1 and CLDN1. Exp Ther Med. 2020;20:155. doi:10.3892/etm.2020.9284.
   PubMed Web of Science ®Google Scholar
• Fei L, Wang Y. microRNA-495 reduces visceral sensitivity in mice with diarrhea-predominant irritable bowel syndrome through suppression of the PI3K/AKT signaling pathway via PKIB. Iubmb Life. 2020;72(7):1468–1480. doi:10.1002/iub.2270.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu X, Wu J, Li S, Han S, Lin Z, Ding S, Jia X, Gong W. Decreased expression of microRNA-510 in intestinal tissue contributes to post-infectious irritable bowel syndrome via targeting PRDX1. Am J Transl Res. 2019;11:7385–7397.
   PubMed Web of Science ®Google Scholar
• Tao W, Dong X, Kong G, Fang P, Huang X, Bo P. Elevated circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in type 2 diabetes mellitus with diarrhea-predominant irritable bowel syndrome. Gastroenterol Res Pract. 2016;2016:1–9. doi:10.1155/2016/9256209.
   Web of Science ®Google Scholar
• Guo J, Lu G, Chen L, Geng H, Wu X, Chen H, Li Y, Yuan M, Sun J, Pei L, et al. Regulation of serum microRNA expression by acupuncture in patients with diarrhea-predominant irritable bowel syndrome. Acupunct Med. 2022;40(1):34–42. doi:10.1177/09645284211027892.
   PubMed Web of Science ®Google Scholar
• Gao J, Xiong T, Grabauskas G, Owyang C. Mucosal serotonin reuptake transporter expression in irritable bowel syndrome is modulated by gut microbiota via mast cell–prostaglandin E2. Gastroenterology. 2022;162(7):1962–1974.e6. doi:10.1053/j.gastro.2022.02.016.
   PubMed Web of Science ®Google Scholar
• Singh P, Lembo A. Emerging role of the gut microbiome in irritable bowel syndrome. Gastroenterol Clin North Am. 2021;50(3):523–545. doi:10.1016/j.gtc.2021.03.003.
   PubMed Web of Science ®Google Scholar
• Higashi T, Arnold TR, Stephenson RE, Dinshaw K, Miller A. Maintenance of the epithelial barrier and remodeling of cell-cell junctions during Cytokinesis. Curr Biol. 2016;26:1829–42. doi:10.1016/j.cub.2016.05.036.
   PubMed Web of Science ®Google Scholar
• Goult BT, Zacharchenko T, Bate N, Tsang R, Hey F, Gingras AR, Elliott PR, Roberts GCK, Ballestrem C, Critchley DR, et al. RIAM and vinculin binding to talin are mutually exclusive and regulate adhesion assembly and turnover. J Biol Chem. 2013;288(12):8238–8249. doi:10.1074/jbc.M112.438119.
   PubMed Web of Science ®Google Scholar
• Konishi S, Yano T, Tanaka H, Mizuno T, Kanoh H, Tsukita K, Namba T, Tamura A, Yonemura S, Gotoh S, et al. Vinculin is critical for the robustness of the epithelial cell sheet paracellular barrier for ions. Life Sci Alli. 2019;2:e201900414. doi:10.26508/lsa.201900414.
   PubMed Web of Science ®Google Scholar
• Yao M, Qiu W, Liu R, Efremov AK, Cong P, Seddiki R, Payre M, Lim CT, Ladoux B, Mège R-M, et al. Force-dependent conformational switch of α-catenin controls vinculin binding. Nat Commun. 2014;5(1):4525. doi:10.1038/ncomms5525.
   PubMedGoogle Scholar
• Twiss F, Le Duc Q, Van Der Horst S, Tabdili H, Van Der Krogt G, Wang N, Rehmann H, Huveneers S, Leckband DE, De Rooij J, et al. Vinculin-dependent cadherin mechanosensing regulates efficient epithelial barrier formation. Biol Open. 2012;1(11):1128–1140. doi:10.1242/bio.20122428.
   PubMed Web of Science ®Google Scholar
• Linsalata M, Riezzo G, D’Attoma B, Clemente C, Orlando A, Russo F. Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study. BMC Gastroenterol. 2018;18:167. doi:10.1186/s12876-018-0888-6.
   PubMed Web of Science ®Google Scholar
• Hanning N, Edwinson AL, Ceuleers H, Peters SA, De Man JG, Hassett LC, De Winte BY, Grover M. Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review. Therap Adv Gastroenterol. 2021;14:1756284821993586. doi:10.1177/1756284821993586.
   Web of Science ®Google Scholar
• Shefa U, Kim MS, Jeong NY, Jung J. Antioxidant and cell-signaling functions of hydrogen sulfide in the central nervous System. Oxid Med Cell Longev. 2018;2018:1–17. doi:10.1155/2018/1873962.
   Web of Science ®Google Scholar
• Koh SJ, Choi Y, Kim BG, Lee KL, Kim DW, Kim JH, Kim JW, Kim JS. Matricellular protein periostin mediates intestinal inflammation through the activation of nuclear factor κB signaling. Plos One. 2016;11:e0149652. doi:10.1371/journal.pone.0149652.
   PubMed Web of Science ®Google Scholar
• Cui XF, Zhou WM, Yang Y, Zhou J, Li XL, Lin L, Zhang HJ. Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndrome. World J Gastroenterol. 2014;20:13521–9. doi:10.3748/wjg.v20.i37.13521.
   PubMed Web of Science ®Google Scholar
• Crowell MD. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol. 2004;141(8):1285–1293. doi:10.1038/sj.bjp.0705762.
   PubMed Web of Science ®Google Scholar
• Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C, Pimentel M. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci. 2012;57:1321–9. doi:10.1007/s10620-012-2033-7.
   PubMed Web of Science ®Google Scholar
• Leite G, Rezaie A, Mathur R, Barlow GM, Rashid M, Hosseini A, Wang J, Parodi G, Villanueva-Millan MJ, Sanchez M, et al. Defining small intestinal bacterial overgrowth by culture and high throughput sequencing. Clin Gastroenterol Hepatol. 2023. doi:10.1016/j.cgh.2023.06.001.
   PubMedGoogle Scholar
• Chassaing B, Raja SM, Lewis JD, Srinivasan S, Gewirtz AT. Colonic microbiota encroachment correlates with dysglycemia in humans. Cell Mol Gastroenterol Hepatol. 2017;4:205–221. doi:10.1016/j.jcmgh.2017.04.001.
   PubMed Web of Science ®Google Scholar
• Rolhion N, Chassaing B. When pathogenic bacteria meet the intestinal microbiota. Philos Trans R Soc Lond B Biol Sci. 2016;371:371. doi:10.1098/rstb.2015.0504.
   Web of Science ®Google Scholar
• Yang W, Xu HW, Lu XR, Xu Q-F, Tao M-H, Dai Y-M. Overexpression of miR-122 impairs intestinal barrier function and aggravates acute pancreatitis by downregulating occludin expression. Biochem Genet. 2022;60:382–394. doi:10.1007/s10528-021-10106-2.
   PubMed Web of Science ®Google Scholar
• Jingushi K, Kashiwagi Y, Ueda Y, Kitae K, Hase H, Nakata W, Fujita K, Uemura M, Nonomura N, Tsujikawa K, et al. High miR-122 expression promotes malignant phenotypes in ccRCC by targeting occludin. Int J Oncol. 2017;51(1):289–297. doi:10.3892/ijo.2017.4016.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhu M, Liu X, Fei L, Shen J, Chen D. miR-122-5p regulates the tight junction of the blood-testis barrier of mice via occludin: miR-122-5p can regulate the tight junction. Basic Clin Androl. 2021;31:7. doi:10.1186/s12610-021-00126-8.
   PubMed Web of Science ®Google Scholar
• Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome? Gut. 2002;51 Suppl 1:i41–4. doi:10.1136/gut.51.suppl_1.i41.
   PubMed Web of Science ®Google Scholar
• Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126(3):693–702. doi:10.1053/j.gastro.2003.11.055.
   PubMed Web of Science ®Google Scholar
• Barbara G, Wang B, Stanghellini V, de Giorgio R, Cremon C, Di Nardo G, Trevisani M, Campi B, Geppetti P, Tonini M, et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology. 2007;132(1):26–37. doi:10.1053/j.gastro.2006.11.039.
   PubMed Web of Science ®Google Scholar
• Holzer P, Holzer-Petsche U. Tachykinin receptors in the gut: physiological and pathological implications. Curr Opin Pharmacol. 2001;1(6):583–590. doi:10.1016/S1471-4892(01)00100-X.
   PubMedGoogle Scholar
• Tack J, Drossman DA. What’s new in Rome IV? Neurogastroenterol Motil. 2017;29. doi:10.1111/nmo.13053.
   Web of Science ®Google Scholar
• Steinhoff MS, von Mentzer B, Geppetti P, Pothoulakis C, Bunnett NW. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. Physiol Rev. 2014;94:265–301. doi:10.1152/physrev.00031.2013.
   PubMed Web of Science ®Google Scholar
• Fritz N, Berens S, Dong Y, Martínez C, Schmitteckert S, Houghton LA, Goebel-Stengel M, Wahl V, Kabisch M, Götze D, et al. The serotonin receptor 3E variant is a risk factor for female IBS-D. J Mol Med (Berl). 2022;100(11):1617–1627. doi:10.1007/s00109-022-02244-w.
   PubMed Web of Science ®Google Scholar
• Mogilyansky E, Rigoutsos I. The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ. 2013;20(12):1603–1614. doi:10.1038/cdd.2013.125.
   PubMed Web of Science ®Google Scholar
• Wu S, Yuan C, Liu S, Zhang Q, Yang Z, Sun F, Zhan S, Zhu S, Zhang S. Irritable bowel syndrome and long-term risk of cancer: a prospective cohort study among 0.5 million adults in UK biobank. Am J Gastroenterol. 2022;117:785–793. doi:10.14309/ajg.0000000000001674.
   PubMedGoogle Scholar
• Morales W, Rezaie A, Barlow G, Pimentel M. Second-generation biomarker testing for irritable bowel syndrome using plasma anti-CdtB and anti-vinculin levels. Dig Dis Sci. 2019;64:3115–3121. doi:10.1007/s10620-019-05684-6.
   PubMed Web of Science ®Google Scholar
• Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M, Glöckner FO. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41:e1. doi:10.1093/nar/gks808.
   PubMed Web of Science ®Google Scholar
• Leite GGS, Morales W, Weitsman S, Celly S, Parodi G, Mathur R, Sedighi R, Barlow GM, Rezaie A, Pimentel M, et al. Optimizing microbiome sequencing for small intestinal aspirates: validation of novel techniques through the REIMAGINE study. BMC Microbiol. 2019;19(1):239. doi:10.1186/s12866-019-1617-1.
   PubMed Web of Science ®Google Scholar
• Illumina. 16S metagenomic sequencing library preparation. San Diego, CA: Illumina; 2013. https://support.illumina.com/downloads/16s_metagenomic_sequencing_library_preparation.html.
   Google Scholar
• Qiagen. CLC Genomics Workbench 23.0.5 product manual. Aarhus, Denmark: Qiagen https://digitalinsights.qiagen.com/
   Google Scholar
• Lu Y, Zhou G, Ewald J, Pang Z, Shiri T, Xia J. MicrobiomeAnalyst 2.0: comprehensive statistical, functional and integrative analysis of microbiome data. Nucleic Acids Res. 2023;51:W310–W318. doi:10.1093/nar/gkad407.
   PubMed Web of Science ®Google Scholar
• Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet Journal. 2011;17:3. doi:10.14806/ej.17.1.200.
   Google Scholar
• Andrews S. FastQC: a quality control tool for high throughput sequence data. 2010. http://www.bioinformatics.babraham.ac.uk/projects/fastqc
   Google Scholar
• Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21. doi:10.1093/bioinformatics/bts635.
   PubMed Web of Science ®Google Scholar
• Anders S, Pyl PT, Huber W. Htseq–a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166–9. doi:10.1093/bioinformatics/btu638.
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8.
   PubMed Web of Science ®Google Scholar
• Alexa A, Rahnenfuhrer J. topGO: enrichment analysis for gene ontology. R package version 1.38.1. 2019.
   Google Scholar
• Mitchell AL, Attwood TK, Babbitt PC, Blum M, Bork P, Bridge A, Brown SD, Chang H-Y, El-Gebali S, Fraser MI, et al. InterPro in 2019: improving coverage, classification and access to protein sequence annotations. Nucleic Acids Res. 2019;47(D1):D351–D360. doi:10.1093/nar/gky1100.
   PubMed Web of Science ®Google Scholar
• Geer LY, Marchler-Bauer A, Geer RC, Han L, He J, He S, Liu C, Shi W, Bryant SH. The NCBI BioSystems database. Nucleic Acids Res. 2010;38:D492–6. doi:10.1093/nar/gkp858.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102.
   PubMed Web of Science ®Google Scholar
• Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739–40. doi:10.1093/bioinformatics/btr260.
   PubMed Web of Science ®Google Scholar
• Fabregat A, Jupe S, Matthews L, Sidiropoulos K, Gillespie M, Garapati P, Haw R, Jassal B, Korninger F, May B, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2018;46(D1):D649–D655. doi:10.1093/nar/gkx1132.
   PubMed Web of Science ®Google Scholar
• Slenter DN, Kutmon M, Hanspers K, Riutta A, Windsor J, Nunes N, Mélius J, Cirillo E, Coort SL, Digles D, et al. WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research. Nucleic Acids Res. 2018;46(D1):D661–D667. doi:10.1093/nar/gkx1064.
   PubMed Web of Science ®Google Scholar
• Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11(3):R25. doi:10.1186/gb-2010-11-3-r25.
   PubMed Web of Science ®Google Scholar
• Ge SX, Jung D, Yao R, Valencia A. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020;36(8):2628–2629. doi:10.1093/bioinformatics/btz931.
   PubMed Web of Science ®Google Scholar
• Svoronos AA, Campbell SG, Engelman DM. MicroRNA function can be reversed by altering target gene expression levels. iScience. 2021;24:103208. doi:10.1016/j.isci.2021.103208.
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi P. A ceRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell. 2011;146:353–8. doi:10.1016/j.cell.2011.07.014.
   PubMed Web of Science ®Google Scholar